Literature DB >> 12181690

Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry.

T Kretschmer1, L T Happel, J D England, D H Nguyen, R L Tiel, R W Beuerman, D G Kline.   

Abstract

BACKGROUND: The axolemmal distribution and density of voltage-gated sodium channels largely determines the electrical excitability of sprouting neurites. Recent evidence suggests that accumulation of sodium channels at injured axonal tips may be responsible for ectopic axonal hyperexcitability and the resulting abnormal sensory phenomena of pain and paresthesias. For future improvement in pain management it is necessary to identify structurally significant generators of autorhythmicity. A first step in this regard will be to determine the predominant types of sodium channels in injured axons. The opportunity to test human specimens from painful and non-painful neuroma is of great value.
METHODS: We employed immunocytochemical methods to investigate if two types of highly specific voltage-gated sodium channel subtypes could be detected in sections of human neuroma.
FINDINGS: Both subtypes of sodium channels PN1 and PN3 accumulated abnormally in human neuromas. The immunoreactive pattern was more pronounced in painful neuromas. This is in contrast to previous reports that focused either on PN1 or PN3 as main generators of hyperexcitability induced pain.
INTERPRETATION: Both, PN1 and PN3 seem to be involved in hyperexcitability induced pain. It can be expected that a variety of other highly specific voltage gated sodium channel subtypes will be detected in regenerating peripheral nerve in the near future, which contribute to the development of neuropathic pain states. Thus, in order to therapeutically control hyperexcitability induced neuropathic pain, it might be worthwhile to develop pharmaceuticals that can selectively block different sodium channel subtypes and subunits.A review of the role of sodium channels in neuropathic pain is implemented in the discussion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181690     DOI: 10.1007/s00701-002-0970-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

Review 1.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 2.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

Review 3.  The role of sodium channels in chronic pain.

Authors:  Simon R Levinson; Songjiang Luo; Michael A Henry
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

4.  Relationship of axonal voltage-gated sodium channel 1.8 (NaV1.8) mRNA accumulation to sciatic nerve injury-induced painful neuropathy in rats.

Authors:  Supanigar Ruangsri; Audrey Lin; Yatendra Mulpuri; Kyung Lee; Igor Spigelman; Ichiro Nishimura
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

5.  Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine.

Authors:  P Chevrier; K Vijayaragavan; M Chahine
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

6.  [Topical ambroxol for the treatment of neuropathic pain: A first clinical observation. German version].

Authors:  K-U Kern; T Weiser
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

7.  Governing role of primary afferent drive in increased excitation of spinal nociceptive neurons in a model of sciatic neuropathy.

Authors:  Graham M Pitcher; James L Henry
Journal:  Exp Neurol       Date:  2008-08-16       Impact factor: 5.330

8.  Sodium channel expression and localization at demyelinated sites in painful human dental pulp.

Authors:  Michael A Henry; Songjiang Luo; Benjamin D Foley; Rachael S Rzasa; Lonnie R Johnson; S Rock Levinson
Journal:  J Pain       Date:  2009-07       Impact factor: 5.820

9.  Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy.

Authors:  Devang Kashyap Thakor; Audrey Lin; Yoshizo Matsuka; Edward M Meyer; Supanigar Ruangsri; Ichiro Nishimura; Igor Spigelman
Journal:  Mol Pain       Date:  2009-03-25       Impact factor: 3.395

10.  Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

Authors:  Mohammed A Nassar; L Caroline Stirling; Greta Forlani; Mark D Baker; Elizabeth A Matthews; Anthony H Dickenson; John N Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.